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1- ACTP, 1 CABG) with in-hospital death of 8% (3 patients: 2 cases
which the dissection progressed retrogradely during PCI and involved
the left main and complicated by cardiogenic shock and 1 case
involving also the aortic root). 21.6% of cases were initially treated
with ﬁbrinolysis which was also signiﬁcantly related with MACE
(p¼0.001). PCI was successful in 99.5% of cases. 2 or more stents were
needed in 50% of cases and the medium stent length was 46.7 32.4
mm [SD]. During a mean angiographic follow-up of 1023 days the 85%
of them didn’t have any images of dissection.
CONCLUSIONS The registry showed that after spontaneous dissec-
tion the prognosis in the long-term follow up is acceptable and most of
the MACE occur during the acute phase. PCI of these types of lesions
are generally successful but usually involve a long stent length. Tor-
tuosity in coronary arteries, previous thrombolysis and the retrograde
progression of dissection during PCI involving the left main are
related to bad prognosis.
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BACKGROUND We compared the effect of culprit-only and multi-
vessel disease percutaneous coronary intervention (MVD-PCI) with
2nd generation drug eluting stent (DES) in ST-segment elevation
myocardial infarction (STEMI) with multivessel disease (MVD).
METHODS From 2009 to 2014, a total of 1541 consecutive patients
with STEMI underwent primary PCI were analyzed retrospectively. Of
all patients, 559 patients (zotarolimus-eluting stent: 32%, everolimus-
eluting stent: 29%, biolimus-eluting stent: 10%, others 29%) with MVD
were chosen and divided into culprit only PCI (n¼270, 48%) and MVD-
PCI (n¼289, 52%). In addition, MVD-PCI was classiﬁed into simulta-
neous PCI at index procedure (n¼210, 38%) and staged PCI (n¼79,
14%) according to the way of PCI. Primary endpoint was cardiovas-
cular (CV) death. The secondary endpoints was major adverse cardiac
and cerebrovascular events (MACCE) including CV death, MI, target
vessel failure (TVF), admission from heart failure and stroke.
RESULTS Over a mean follow-up period of 2319 months, there were 69
(12%) CV death and 114 (20%) MACCE. Compared with culprit only PCI,
MVD-PCI had a numerically lower CV death rate (10.1% vs. 14.7%, HR 0.64,
p¼0.07, CI 0.399w1.041, Figure A) and signiﬁcantly lower MACCE rate
(17.5% vs. 23.4%, HR 0.66, p¼0.03, CI 0.458w0.961, Figure B). Of MVD-
PCI patients, staged PCI showed numerically lower CV death rate (5.1%
vs. 11.9%, HR 0.40, p¼0.09, CI 0.141w1.167) and MACCE (12.7% vs.
19.0%, HR 0.63, p¼0.20, CI 0.319w1.277) compared to simultaneous PCI.
CONCLUSIONS In 2nd generation DES era, MVD-PCI was associated
with better long term outcomes compared to culprit-only PCI in pa-
tients with STEMI with MVD.
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BACKGROUND Spontaneous coronary artery dissection (SCAD) is an
acute coronary event of a non-atherosclerotic etiology, and predom-
inantly affects younger women. SCAD remains underdiagnosed and a
rare cause of myocardial infarction (MI) in men. Predisposing and
precipitating factors remains poorly understood in men with SCAD.
METHODS Men with SCAD evaluated at Vancouver General Hospital
were included in this cohort. Angiographic SCAD diagnosis was cate-
gorized as type 1 (multiple lumen), 2 (diffuse stenosis), or 3 (mimic
atherosclerosis). Fibromuscular dysplasia (FMD) screening of renal,
iliac, and cerebrovascular arteries were performed with catheter
angiography, or computed-tomographic/magnetic-resonance angiog-
raphy. Baseline predisposing and precipitating conditions, angio-
graphic, revascularization, and in-hospital events were recorded.
RESULTS We identiﬁed 19menwith SCAD; their mean agewas 46.7 8.9
years.Aprecipitatingstressorwas readily identiﬁed in14/19 (73.7%),with8/
19 (42.1%) performing extreme isometric exertion prior to SCAD. The other
factors included 4 (21.1%) emotional/social stressors, 1(5.2%)work stressor,
and 1(5.2%) due to severe illness. FMDwas diagnosed in 9 (47.4%) men (4
had isometric exertion prior to SCAD). All presented with MI. ECG was
abnormal in 68.4% (13/19) with 10.5% (2/19) having ST-segment elevation.
Three (15.8%) men had multi-vessel SCAD. Majority had type 2 angio-
graphic SCAD 57.9% (11), 36.8% (7) had type 1, and 5.3% (1) had type 3. The
majority 84.2% (16) were treated conservatively, 15.8% (3) underwent
percutaneous coronary intervention (2 with DES and 1 with BMS). One pa-
tient diedwithin 30 days due to septic shock from ulcerative colitis. During
mean follow-up of 10  13 months, 2 (10.5%) had a recurrent SCAD event.
Onepatient alsohaddissection of his carotid arteryprior to his SCADevent.
CONCLUSIONS In our small cohort of men with SCAD, patients either
had FMD or performed severe isometric exertion as their predisposing
or precipitating factor for their SCAD event.
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BACKGROUND It has been reported that a major cause of coronary vaso-
spastic angina (VSA) is endothelial dysfunction of the coronary artery.
Some studies showed that serum uric acid is correlated with endothelial
dysfunction. However, It is controversial that uric acid is associated with
coronary vasospastic angina and there has been no study for uric acid to
become prognostic factor in coronary vasospastic angina.
METHODS A total 3828 patients (pts) undergoing coronary angiog-
raphy with acetylcholine provocation test from Mar 2004 to Sep 2012
from prospective spasm registry of Cardiovascular Center of Korea
University Guro Hospital were enrolled. The deﬁnition of positive
coronary spasm test was deﬁned as coronary vasospasm of more than
70%. The level of serum uric acid was categorized into each quartile
group; less than 3.8, 3.9w4.7, 4.8w5.7, and more than 5.8 mg/dL.
Major adverse cardiovascular events (MACEs) were deﬁned as the
composite end-point consisted of recurrent chest pain requiring
repeat coronary angiography, cardiac death, myocardial infarction,
and cerebrovascular disease. The duration of follow-up for MACEs
was 3-year. The rate of follow-up was the 2340 of 3828 pts (61.1%).
RESULTS There was no statistical signiﬁcance in the level of serum
uric acid between negative and positive coronary spasm groups in
B68 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5female gender but in male gender, uric acid was higher in negative
coronary artery spasm (Table 1). However, when adjusted by age, the
statistical signiﬁcance disappeared (OR, 0.965; 95% CI, 0.898-1.037 ;
P-value, 0.335). The incidence of MACE was 11.1% in male gender
and 8.6% in female gender. In male gender, the serum uric acid
level between the groups with and without MACE was similar but in
female gender, the level of uric acid was higher in the group with
MACE, compare to the group without MACE. However, when
adjusted by age, uric acid was not associated with MACE (Table 2).
CONCLUSIONS In our study, uric acid was neither the risk factor nor
prognostic factor for clinical outcomes during 3-year follow-up period
in coronary vasospastic angina regardless of gender.
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BACKGROUND Increased platelet inhibition by prasugrel has been
shown to result in reduced ischemic events along with greater
bleeding hazards in patients with acute coronary syndromes (ACS)
treated with percutaneous coronary intervention (PCI). Yet, there is
limited experience with the use of prasugrel in routine practice. We
evaluated 1-year outcomes with routine prasugrel treatment after ACS
in a large-scale registry.
METHODS The Rijnmond Collective Cardiology Research (CCR) regis-
try is a prospective, observational study with enrollment of 4,259 PCI-
treated ACS patients with 1-year follow-up in the larger region of Rot-
terdam, the Netherlands. Based on implemented hospital protocols, all
patients received prasugrel as ﬁrst-choice antiplatelet agent, unless
contraindicated, including pretreatment before arrival at cathlab either
pre-hospital (ambulance), in referring hospital or in-hospital (emer-
gency room or coronary care unit), whenever possible. All events are
validated by an independent clinical endpoint committee.
RESULTS A total number of 2729 patients (64%) received prasugrel in
the registry after the index event. Half of these patients presented with
ST-elevation myocardial infarction, 77% were men, and mean age was
60.110.8 years. Reasons for not subscribing prasugrel included, for
instance, age >75 years (n¼611 [42% of pts receiving clopidogrel]) and
previous stroke or TIA (n¼270 [18.4%]). At the time of current abstract
submission, 70% of all study events were validated. At 1 year, the pri-
mary endpoint, a composite of all-cause death and myocardial infarc-
tion, occurred in 2.9% of patients receiving prasugrel. All-cause deathoccurred in 2.0%, myocardial infarction in 1.0%, target-vessel revas-
cularization in 2.1%, stent thrombosis in 0.5%, and stroke in 0.3% of the
prasugrel-treated patients. The safety endpoint of all Thrombolysis in
Myocardial Infarction major bleeding episodes, whether related or not
related to coronary-artery bypass grafting was observed in 1.1% of pa-
tients receiving prasugrel. At TCT 2015, the remaining events will be
validated and available for presentation.
CONCLUSIONS Early results from the CCR study show that prasugrel-
treated ACS patients have low rates of ischemic events, including
overall mortality, and no excess rates of major bleeding in routine
practice up to 1 year post-PCI.
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BACKGROUND Coronary artery disease (CAD) is a serious public and
economic health problem. Coronary angiography is a gold standard for
diagnosing CAD and is indicated in patients with 61-90% pre-test
probability of the disease when the diagnosis cannot be made on
clinical grounds alone and when revascularization is being consid-
ered. Around 25% of coronary angiograms demonstrate normal ar-
teries. The natural history of normal coronary angiogram is poorly
understood. We evaluated the progression of disease in patients with
normal coronary angiography and assessed the overall survival and
event-free survival from acute myocardial infarction in these patients.
METHODS We interrogated the Central Cardiac Audit Database
(CCAD) between November 2005 and December 2013 to identify pa-
tients with normal or ’near-normal’ coronary angiography. De-
mographic, clinical and angiographic data was recorded. This
database was linked with the Patient Episode Database for Wales
(PEDW) and the datasets from the Ofﬁce for National Statistics (for
mortality) using the Secure Anonymized Information Linkage (SAIL)
databank. This allowed for the extraction of information from all the
sources above on the basis of the International Statistical Classiﬁca-
tion of Diseases (ICD-10) using the Structured Query Language (SQL).
RESULTS Out of over 20,000 patients undergoing coronary angiog-
raphy between November 2005 and December 2013, 5032 patients had
normal coronaries and minor CAD. Of 5032 patients, 136 underwent
repeat angiography, with 131(96.3%) and 5(3.7%) patients having two
and three repeat investigations respectively. Mean time between
procedures was 3.3 (1.82) years. Of those 136 patients, at the median
follow up of 6.8 years, no change in disease progression was
demonstrated in 108(79.4%) patients on the follow up studies. In the
remaining 28 (20.6%) patients, normal coronaries progressed to minor
CAD. No patients progressed beyond minor CAD. Patients with normal
coronaries had signiﬁcant better survival than patients with minor
CAD (p<0.05), but survival free from MI was >99.5% in both groups at
the median of 5 years follow up. (p¼0.09)
CONCLUSIONS Normal coronary angiography and minor CAD is un-
likely to progress to signiﬁcant disease at 7 years and the incidence of
MI in these patients is rare at 5 years. Therefore, repeating coronary
angiography within at least 5 years is not indicated.
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